Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2026-07-15 Sale | 2026-07-15 6:35 pm | Nuvalent Inc. | NUVL | Bogle Grant C. Director | 5,577 | $0 | $0 | 0 (Direct) | View |
| 2022-08-12 Sale | 2022-08-16 6:52 pm | Epizyme Inc. | EPZM | Bogle Grant C. President and CEO | 259,170 | $0 | $0 | 0 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2026-11-09 Option Award | 2026-11-09 4:31 pm | N/A 2036-11-09 | Immuneering Corp | IMRX | Bogle Grant C. Director | 66,700 | $0 | 66,700 (Direct) | View |
| 2026-07-15 Equity Swap | 2026-07-15 6:35 pm | N/A N/A | Nuvalent Inc. | NUVL | Bogle Grant C. Director | 3,714 | $124 | 0 (Direct) | View |
| 2026-06-16 Option Award | 2026-06-18 4:32 pm | N/A N/A | Nuvalent Inc. | NUVL | Bogle Grant C. Director | 3,444 | $0 | 9,291 (Direct) | View |
| 2025-06-18 Option Award | 2025-06-20 4:33 pm | N/A 2035-06-18 | Nuvalent Inc. | NUVL | Bogle Grant C. Director | 6,794 | $0 | 9,994 (Direct) | View |
| 2024-12-05 Option Award | 2024-12-09 06:54 am | N/A 2034-12-05 | Nuvalent Inc. | NUVL | Bogle Grant C. Director | 8,051 | $0 | 8,051 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 9:00 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 1,217,500 | $0 | 259,170 (Direct) | View |
| 2022-08-09 Tax Withholding | 2022-08-11 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 395,083 | $1.41 | 259,170 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 800,000 | $1.39 | 259,170 (Direct) | View |
| 2022-08-09 Tax Withholding | 2022-08-11 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 746,307 | $1.39 | 259,170 (Direct) | View |
| 2022-08-09 Exercise | 2022-08-11 9:00 pm | N/A N/A | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 417,500 | $1.41 | 259,170 (Direct) | View |
| 2022-03-17 Option Award | 2022-03-21 6:06 pm | N/A 2032-03-16 | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 800,000 | $0 | 800,000 (Direct) | View |
| 2022-02-02 Option Award | 2022-02-04 4:15 pm | N/A 2032-02-01 | Epizyme Inc. | EPZM | Bogle Grant C. See Remarks | 505,000 | $0 | 600,560 (Direct) | View |